← All causality assessments
Causality assessment · Expected pharmacological effect

Methamphetamine Hydrochloride and Drug Abuse: is the FAERS signal real?

n=238 co-reports · PRR 55.7 · ROR 71.3
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Expected pharmacological effect

Methamphetamine Hydrochloride ↔ Drug Abuse

n=238 co-reports · PRR 55.7 · ROR 71.3

Methamphetamine is a CNS stimulant of high abuse potential. Drug abuse is the expected consequence of its powerful dopamine-releasing properties: methamphetamine produces intense euphoria and has high addiction liability (Schedule II). 8,719 co-reports (PRR 27.5) reflect widespread recreational use and medical use for ADHD. The label carries a boxed warning for abuse, dependence, and misuse.

Boxed warning: methamphetamine label (abuse/dependence/misuse). DEA scheduling.

Bradford Hill viewpointStatusNote
Temporality (necessary)metDocumented in label
StrengthmetPRR 27.5 with 8,719 co-reports
ConsistencymetReproduced across stimulant class
SpecificitymetSpecific to dopamine-releasing agents
Biological gradientmetTolerance and escalation documented
PlausibilitymetDopamine-release mechanism established
CoherencemetCoherent with stimulant pharmacology
Experimentn/aUnethical to randomise
AnalogymetOther stimulants class-wide

This table is this page's own qualitative read of the literature cited above, not an automated or citation-gated assessment — see the note at the bottom of this page.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for Methamphetamine captured drug abuse as a tracked adverse event in a usable structure. ADHD RCTs measure efficacy; abuse liability assessed in separate studies.